First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease. (American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005)

(untitled) - Baigent, C; Landray, M; Leaper, C; Altmann, P; Armitage, J; Baxter, A; Cairns, H; Collins, R; Foley, R; Frighi, V; Kourellias, K; Ratcliffe, P; et al.